Therapeutic Effect of Transplanted Human Wharton’s Jelly Stem Cell-Derived Oligodendrocyte Progenitor Cells (hWJ-MSC-derived OPCs) in an Animal Model of Multiple Sclerosis

NT-3-secreting human umbilical cord mesenchymal stromal cell transplantation for the treatment of acute spinal cord injury in rats

(2011) Ai-Jia Shang et al.   BRAIN RESEARCH

Differentiation of human fetal mesenchymal stem cells into cells with an oligodendrocyte phenotype

(2011) Nigel L. Kennea et al.   CELL CYCLE

Induction of oligodendrocyte differentiation from adult human fibroblast-derived induced pluripotent stem cells

(2011) Shin-ichiro Ogawa et al.   IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

Differentiation of cryopreserved human umbilical cord blood-derived stromal cells into cells with an oligodendrocyte phenotype

(2010) Yong-Chun Luo et al.   IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

Human Wharton’s jelly cells can be induced to differentiate into growth factor-secreting oligodendrocyte progenitor-like cells

(2009) Hong-Tian Zhang et al.   DIFFERENTIATION

Cografted Wharton’s Jelly Cells-derived Neurospheres and BDNF Promote Functional Recovery After Rat Spinal Cord Transection

(2009) Liang Zhang et al.   NEUROCHEMICAL RESEARCH

Regeneration and repair in multiple sclerosis: The role of cell transplantation

(2009) Stefano Pluchino et al.   NEUROSCIENCE LETTERS

Stem and progenitor cell therapies: recent progress for spinal cord injury repair

(2008) J. Louro et al.   NEUROLOGICAL RESEARCH